Beta Bionics, Inc. Common Stock

BBNXNASDAQ • USD
ThemeMedical Devices & HealthTech›Wearable Medical Devices
13.76 USD
↘ 0.14 (0.97%)🟢LIVE (AS OF 12:03 PM EDT)
🟢Market: OPEN
Open?$13.78
High?$14.18
Low?$13.55
Prev. Close?$13.89
Volume?136.9K
Avg. Volume?766.0K
VWAP?$13.91
Rel. Volume?0.18x
Bid / Ask
Bid?$11.89 × 100
Ask?$13.80 × 100
Spread?$1.91
Midpoint?$12.85
Valuation & Ratios
Market Cap?619.0M
Shares Out?44.6M
Float?37.7M
Float %?84.8%
P/E Ratio?N/A
P/B Ratio?2.28
EPS?-$1.49
Dividend?0.00%
Ex-Dividend?N/A

Beta Bionics, Inc. Common Stock (BBNX) trades at $13.76 per share. Technicals currently rate "Buy" while our fundamental analysis reads "Neutral". This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. On valuation, BBNX trades roughly in line with sector averages — neither particularly cheap nor expensive.

Technical & fundamental data as of Jun 5, 2026.

News
Profile
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.
Themes
Medical Devices & HealthTech›Wearable Medical DevicesDigital Health & Telemedicine›Remote Patient Monitoring
Employees
423
Market Cap
554.8M
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Website
www.betabionics.com
Listed
2025-01-30
Address
11 HUGHES
IRVINE, CA 92618
Phone: 949-427-7785
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
100
Momentum?
98
Short Sent.?
50
Piotroski F-Score?0/9Weak
Altman Z-Score?9.80Safe
Confidence?45%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?15.10%High
Short Interest?5.7M
Days to Cover?9.1
Free Float37.7M
Avg Daily Volume624.5K
Settlement Date2026-05-15
Financial Health
Current Ratio?10.69Strong
Quick Ratio?9.67Strong
Cash Ratio?1.30Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
83/100
P/E?
N/A▾
P/B?
Peers
100
S&P
68
2.28CHEAP▾
P/S?
Peers
100
S&P
25
5.61FAIR▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-7.8CHEAP▾
EV/Sales?
Peers
100
S&P
33
5.34FAIR▾
Returns & Efficiency
ROE?
S&P
7
-24.5%WEAK▾
ROA?
S&P
3
-21.8%WEAK▾
Cash Flow & Enterprise
FCF?$-61123000
Enterprise Value?$588.8M
Fundamentals ratios updated end of day
MarketsMoversWatchlist